As the global incidence of these infections rises due to factors such as climate change, urbanization, and international travel, demand for accurate and rapid testing solutions has increased. The market features various diagnostic tools, including molecular tests, immunoassays, and cultural methods. Recent advancements include the development of more sensitive and portable molecular tests. Additionally, collaborations between public health agencies and diagnostic companies aim to improve global response capabilities, enhancing market growth.
Frequently Asked Questions
The market is segmented based on Global Arthropod-Borne Viral Infections Testing Market Segmentation, By Test Type (Molecular Tests, Cultural Tests, Immunoassays, and Others), End User (Hospitals, Research Centers, and Diagnostic Centers) – Industry Trends and Forecast to 2031
.
The Global Arthropod Borne Viral Infections Testing Market size was valued at USD 1.14 USD Billion in 2023.
The Global Arthropod Borne Viral Infections Testing Market is projected to grow at a CAGR of 5.65% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
